Records containing: Major Depressive Disorder
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-12-23An 8-week, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multi-center Study of the Efficacy and Safety of Agomelatine 0.5 mg and 1 mg Sublingual Tablets Administered Once Daily in Patients With Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2020-12-23An 8-week, Multicenter, Randomized, Double-blind, Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine 25 or 50 mg Given Once Daily in the Treatment of Major Depressive Disorder (MDD) Followed by a 52-week Open-label Treatment With Agomelatine 25 or 50 mg
-
CLINICAL_TRIALS study record update · 2020-12-17The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental Health
-
CLINICAL_TRIALS study record update · 2020-12-17A Randomized, Double-Blind, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Safety of 2 Fixed Doses (5.0 mg or 2.5 mg) of MIN-117 in Adult Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2020-12-07Internet Based Cognitive Behavioral Therapy Effects on Depressive Cognitions and Brain Function
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-12-01"Brexpiprazole (Rexulti™) Safety and Efficacy Among Filipino Patients (RAISE) - A Post Marketing Surveillance Program"
-
CLINICAL_TRIALS study record update · 2020-11-25HEC113995-A Phase I,Double-Blind, Placebo-Controlled, Multiple Oral Dose, Safety, Tolerability, Pharmacokinetics and Food Effect Study in Healthy Chinese Subjects
-
CLINICAL_TRIALS study record update · 2020-11-12The Effectiveness of Group CBT and Exercise in Management of Depression: A Three Arm Randomized Controlled Pilot Trial
-
CLINICAL_TRIALS study record update · 2020-11-10A Phase 1, Two Stage, Open Label, Randomized, Single Dose, Comparative Study to Evaluate the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine Product in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2020-11-09A Naturalistic Study of Serial Infusion of Low-dose Ketamine for Treatment Resistant Depressive Disorders in an Academic Psychiatric Hospital: The UTHealth Ketamine Project
-
CLINICAL_TRIALS study record update · 2020-11-09Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness
-
CLINICAL_TRIALS study record update · 2020-11-04A Collaborative Investigation of Predictors of Relapse in Major Depressive Disorder: CAN-BIND-1 Extension Study
-
CLINICAL_TRIALS study record update · 2020-11-03CAN-BIND (Canadian Biomarker Integration Network for Depression): Long-Term Follow Up Study
-
CLINICAL_TRIALS study record update · 2020-10-30Evaluation of Efficacy of Lycium Barbarum Polysaccharide in Patients With Major Depressive Disorder: a Randomized,Placebo-controled Trial
-
CLINICAL_TRIALS study record update · 2020-10-30A Multicenter,Randomized,Open-label,Parallel-group,and Adaptive Design Clinical Study to Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2020-10-30A Multicenter, Randomized, Double-blind, Placebo Controlled Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets in Patients With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2020-10-28A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Clinical Study to Assess the Safety, Tolerability and Pharmacokinetics of HEC113995 PA•H2O Tablets in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2020-10-28Intra-nasal vs. Intra-venous Ketamine Administration as an add-on to Antidepressant Therapy
-
CLINICAL_TRIALS study record update · 2020-10-28Feasibility of Internet-delivered Cognitive Behavior Therapy for Adolescents With Mild to Moderate Depression: A Randomized Pilot Study Comparing Therapist-guided vs. Self-guided ICBT vs. Treatment as Usual
-
CLINICAL_TRIALS study record update · 2020-10-20Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder: An Open-Label Trial
-
CLINICAL_TRIALS study record update · 2020-10-19A Double-blind, Placebo-controlled, Randomized, Multicenter Proof-of-principle Trial of Adjunctive Minocycline for Patients With Unipolar Major Depressive Disorder (MDD)
-
CLINICAL_TRIALS study record update · 2020-10-19A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression
-
CLINICAL_TRIALS study record update · 2020-10-19Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion (LEAP-DB): A Multicenter, Randomized, Blinded Outcome Study of EEG-guided Treatment With Duloxetine Versus Bupropion in Adults With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2020-10-19Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram (LEAP-SE): A Multicenter, Randomized, Blinded Outcome Study of EEG-guided Treatment With Sertraline Versus Escitalopram in Adults With Major Depressive Disorder
-
CLINICAL_TRIALS study record update · 2020-10-14eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients